AiCure

ERT

ERT expands corporate presence in Japan

Wednesday, January 16, 2013 09:26 AM

ERT, a global technology-driven provider of health outcomes research services, has completed registration for Kabushiki Kaisha (KK) in Japan and has formed a fully-owned subsidiary, ERT Asia Group.

More... »


ERT launches enhanced platform to streamline data collection, analysis and processing

Friday, September 7, 2012 11:57 AM

ERT, a global technology-driven provider of health outcomes services, has launched an enhanced clinical research workflow technology designed to streamline data collection, analysis and processing in clinical trials.

More... »


ERT introduces enhanced platform to streamline clinical trial data collection

Tuesday, August 28, 2012 12:31 PM

Philadelphia-based ERT, a global provider of health outcomes services, has launched an enhanced clinical research workflow technology designed to streamline data collection, analysis and processing in clinical trials. The new offering, which comprises the EXPERT3 workflow platform and MyStudyPortal3 reporting engine, can simultaneously process health outcomes data across cardiac safety, Clinical Outcome Assessment (COA)/ePRO and respiratory studies. The platform offers users a simple way to process multiple types of data accurately, leading to fewer errors in studies.

More... »

ERT granted patents on clinical trial participant compliance

Tuesday, July 17, 2012 02:42 PM

Philadelphia-based ERT, a global technology-driven provider of health outcomes services to sponsors and CROs, has received two additional patents from the U.S. Patent and Trademark Office (U.S. Patent No. 8,065,180 and U.S. Patent No. 8,145,519).  The patents are titled System for Clinical Trial Subject Compliance and were acquired by ERT as part of its recent acquisition of invivodata.

More... »

ERT acquires invivodata

Monday, July 9, 2012 01:38 PM

ERT, a global technology-driven provider of health outcomes services, has decided to acquire invivodata, a provider of electronic Patient Reported Outcomes (ePRO) solutions and consulting services, based in Pittsburgh, Penn.

More... »

Genstar Capital completes ERT acquisition

Thursday, July 5, 2012 09:12 AM

Genstar Capital, a private equity firm, has completed its acquisition of ERT, a global technology-driven provider of health outcomes, in a take-private transaction valued at approximately $400 million.

More... »

ERT launches new corporate web site

Wednesday, February 15, 2012 03:52 PM

ERT, a global technology-driven provider of health outcomes services and customizable medical devices, has launched a new corporate web site.

More... »

ERT names Kleiman Chief Medical Officer

Friday, July 8, 2011 12:36 PM

ERT, a global technology-driven provider of clinical services and customizable medical devices, has named Robert Kleiman Chief Medical Officer, in addition to his current role as Vice President of Global Cardiology. 

More... »

ERT appoints of new president and CEO

Monday, May 2, 2011 12:39 PM

eResearchTechnology (ERT), a global technology-driven provider of medical devices to bio-pharmaceutical organizations and a provider for centralized cardiac safety and respiratory services in drug development, has appointed Jeffrey S. Litwin, M.D. as its new president and chief executive officer and as a member of the board.

More... »

ERT awarded over $10 Million in ePRO business

Thursday, April 14, 2011 11:59 AM

ERT, a provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations, was awarded three new contracts with pharmaceutical companies, totalling over $10 million for its electronic patient reported outcomes (ePRO) business.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs